Who Paid My Doc
Amy Derosa
Plastic and Reconstructive Surgery West Bloomfield, MI Doctor of Osteopathy
NPI 1598971327 CMS profile 27205
33200 W 14 Mile Rd Ste 180, West Bloomfield, MI 48322
General payments
$1,935
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Amy Derosa of West Bloomfield, MI is reported in the CMS Open Payments database as having received $1,935 across 41 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 47th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $72 | 3 | |
| 2024 | General | $20 | 1 | |
| 2023 | General | $167 | 1 | |
| 2022 | General | $150 | 6 | |
| 2021 | General | $1,106 | 18 | |
| 2020 | General | $66 | 3 | |
| 2019 | General | $354 | 9 |
Beside peers
- Amy Derosa
- Plastic and Reconstructive Surgery median
- Middle half of Plastic and Reconstructive Surgery
- National median
In program year 2025, general payments to Amy Derosa were reported at $72. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.
Show as a table
| Year | Amy Derosa | Plastic and Reconstructive Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $354 | $335 | $121–$1,264 | $163 |
| 2020 | $66 | $162 | $57–$417 | $114 |
| 2021 | $1,106 | $245 | $89–$735 | $132 |
| 2022 | $150 | $325 | $120–$932 | $149 |
| 2023 | $167 | $343 | $129–$999 | $160 |
| 2024 | $20 | $390 | $141–$1,085 | $164 |
| 2025 | $72 | $442 | $150–$1,242 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 4 drugsPart D claims
73
Drug cost
$236
Branded share of claims
27.4%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Cephalexin | Generic | 19 | $113 | |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 20 | $62 | |
| Ondansetron Hcl | Generic | 20 | $37 | |
| Methocarbamol | Generic | 14 | $25 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.
Records
41 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Plastic and Reconstructive Surgery in Michigan
Michael Meininger
Plastic and Reconstructive Surgery · Bloomfield Hills, MI
Dunya Atisha
Plastic and Reconstructive Surgery · Detroit, MI
Barak Tanzman
Plastic and Reconstructive Surgery · Berkley, MI
Melek Kayser
Plastic and Reconstructive Surgery · Saint Clair Shores, MI
Theodore Kung
Plastic and Reconstructive Surgery · Ann Arbor, MI
Pravin Puri
Plastic and Reconstructive Surgery · Troy, MI
Related records
Plastic and Reconstructive Surgery in Michigan
Practitioners in the same specialty and state, ranked by reported value.
All Plastic and Reconstructive Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Michigan
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.